The deregulation of PLC signaling is associated with many brain diseases such as Alzheimer’s Disease (AD), Huntington’s Disease (HD), Epilepsy, Schizophrenia, Bipolar disorder, and Depression (Yang et al., 2016). Here, HSPG2 is linked to Alzheimer disease.